Therapeutic Asset Ratings
174 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Bcma Car T Cells
Amyloidosis
Zhejiang University
Early P1
C
(39)
Bcma Car T Cells
Autoimmune Hemolytic Anemia
Zhejiang University
Early P1
C
(39)
Bcma Car T Cells
POEMS Syndrome
Zhejiang University
Early P1
C
(39)
Bcma Car T Cells
Vasculitis
Zhejiang University
Early P1
C
(39)
Bcma Targeted Car T-Cells
Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Car-Nk Cell
Malignant Pancreatic Neoplasm
Zhejiang University
Early P1
C
(39)
cd19/bcma car t-cells
Amyloidosis
Zhejiang University
Early P1
C
(39)
cd19/bcma car t-cells
Autoimmune Hemolytic Anemia
Zhejiang University
Early P1
C
(39)
cd19/bcma car t-cells
POEMS Syndrome
Zhejiang University
Early P1
C
(39)
cd19/bcma car t-cells
Vasculitis
Zhejiang University
Early P1
C
(39)
cd19/bcma-targeted car-t cells
Non-Hodgkin's Lymphoma Refractory
Zhejiang University
Early P1
C
(39)
cdh17 car-t
Gastric Cancer
Zhejiang University
Early P1
C
(39)
cdh17 car-t
Multiple Cancer
Zhejiang University
Early P1
C
(39)
cdh17 car-t
Pancreatic Ductal Adenocarcinoma
Zhejiang University
Early P1
C
(39)
Cyclophosphamide
Multiple Cancer
Zhejiang University
Early P1
C
(39)
Fast Laco-Stim Cdh17 Car-T
Gastric Cancer
Zhejiang University
Early P1
C
(39)
Fast Laco-Stim Cdh17 Car-T
Multiple Cancer
Zhejiang University
Early P1
C
(39)
Fast Laco-Stim Cdh17 Car-T
Pancreatic Ductal Adenocarcinoma
Zhejiang University
Early P1
C
(39)
Fludarabine
Advanced Biliary Cancer
Zhejiang University
Early P1
C
(39)
Fludarabine
Multiple Cancer
Zhejiang University
Early P1
C
(39)
Humanized Cd19 Car-T Cells
B-Cell Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Metabolically Armed Cd19 Car-T Cells
B-Cell Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Murine Cd19 Car-T Cells
Non-Hodgkin Lymphoma
Zhejiang University
Early P1
C
(39)
Anti Cd30 Car-T Cell
Anaplastic Large Cell Lymphoma
Zhejiang University
Early P1
C
(38)
Anti Cd30 Car-T Cell
Angioimmunoblastic T-Cell Lymphoma
Zhejiang University
Early P1
C
(38)
Showing 101 to 125 of 174 assets
Previous
Page 5 of 7
Next
